Efficacy of a novel method: VaSodilator injection via the over-the-wire lumen during drug-coated balloon dilatation to prevent the slow-flow phenomenon in treatment of femoropopliteal lesions

Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K, POPCORN Investigators (2023) Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc 12(1):e025677

Article  PubMed  Google Scholar 

Zeller T, Brodmann M, Ansel GM, Scheinert D, Choi D, Tepe G, Menk J, Micari A (2022) Paclitaxel-coated balloons for femoropopliteal peripheral arterial disease: final 5-year results of the IN.PACT global study. EuroIntervention 18(11):e940–e948

Article  PubMed  PubMed Central  Google Scholar 

Shimada T, Shima Y, Takahashi K, Miura K, Takamatsu M, Ikuta A, Habara S, Tanaka H, Goto T, Izumiya Y, Kadota K (2022) Delayed stenosis regression after drug-coated balloon angioplasty for femoropopliteal artery lesions. Heart Vessels 37(5):730–737

Article  PubMed  Google Scholar 

Kodama K, Soga Y, Tomoi Y, Sakai N, Imada K, Katsuki T, Tabata H, Ando K, Nakagawa Y (2024) Difference in 1-year late lumen loss between high- and low-dose paclitaxel-coated balloons for femoropopliteal disease. Heart Vessels 39(7):582–588

Article  PubMed  Google Scholar 

Katsanos K, Spiliopoulos S, Teichgräber U, Kitrou P, Del Giudice C, Björkman P, Bisdas T, de Boer S, Krokidis M, Karnabatidis D (2022) Editor’s choice—risk of major amputation following application of paclitaxel coated balloons in the lower limb arteries: a systematic review and Meta-analysis of randomised controlled trials. Eur J Vasc Endovasc Surg 63(1):60–71

Article  PubMed  Google Scholar 

Thomas SD, McDonald RR, Varcoe RL (2014) Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon. J Vasc Surg 59:520–523

Article  PubMed  Google Scholar 

Torii S, Yahagi K, Mori H, Harari E, Romero ME, Kolodgie FD, Young B, Ragheb A, Virmani R, Finn AV (2018) Biologic drug effect and particulate embolization of drug-eluting stents versus drug-coated balloons in healthy swine femoropopliteal arteries. J Vasc Interv Radiol 29(7):1041-1049.e3

Article  PubMed  Google Scholar 

Torii S, Jinnouchi H, Sakamoto A, Romero ME, Kolodgie FD, Virmani R, Finn AV (2019) Comparison of biologic effect and particulate embolization after femoral artery treatment with three drug-coated balloons in healthy swine model. J Vasc Interv Radiol 30(1):103–109

Article  PubMed  Google Scholar 

Tang TY, Sulaiman MSB, Soon SXY, Yap CJQ, Patel A, Chong TT (2022) Slow-flow phenomena following lower limb paclitaxel- and sirolimus-coated balloon angioplasty in the setting of chronic limb threatening ischaemia-a case series. Quant Imaging Med Surg 12(3):2058–2065

Article  PubMed  PubMed Central  Google Scholar 

Yoshikawa M, Torii S, Aihara K, Ito M, Nakamura N, Noda S, Yoshikawa A, Utsunomiya S, Nakazawa Md G, Ikari Y (2023) Differences in biologic drug effects and distal particulate embolization in three paclitaxel-coated balloons for femoropopliteal lesions in a rabbit model. J Endovasc Ther. https://doi.org/10.1177/15266028231161215

Article  PubMed  Google Scholar 

Farber A (2018) Chronic limb-threatening ischemia. N Engl J Med 379(2):171–180

Article  PubMed  Google Scholar 

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 Suppl S:S5–S67

Article  PubMed  CAS  Google Scholar 

Rocha-Singh KJ, Zeller T, Jaff MR (2014) Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 83(6):E212–E220

Article  PubMed  Google Scholar 

Soga Y, Iida O, Hirano K, Suzuki K, Tosaka A, Yokoi H, Nobuyoshi M (2011) Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery. J Vasc Surg 54(4):1058–1066

Article  PubMed  Google Scholar 

Kawarada O, Fujihara M, Higashimori A, Yokoi Y, Honda Y, Fitzgerald PJ (2012) Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv 80(5):861–871

Article  PubMed  Google Scholar 

Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, Yokoi Y (2017) Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther 24(3):367–375

Article  PubMed  Google Scholar 

Shirai S, Hirano K, Mori S, Makino K, Honda Y, Tsutsumi M, Sakamoto Y, Kobayashi N, Araki M, Yamawaki M, Ito Y (2021) Frequency, predictors, and effect of the slow-flow phenomenon after drug-coated balloon angioplasty for femoropopliteal lesions. Heart Vessels 36(12):1818–1824

Article  PubMed  Google Scholar 

Kloner RA, Ganote CE, Jennings RB (1974) The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54(6):1496–1508

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T (1992) Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85(5):1699–1705

Article  PubMed  CAS  Google Scholar 

Wang X, Nie SP (2011) The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovasc Diagn Ther 1(1):37–43

PubMed  PubMed Central  Google Scholar 

Chalikias G, Tziakas D (2021) Slow coronary flow: pathophysiology, clinical implications, and therapeutic management. Angiology 72(9):808–818

Article  PubMed  CAS  Google Scholar 

Mikaeilvand A, Hajizadeh R, Bateni A, Yahyapour Z (2022) Long-term prognosis in patients with coronary slow flow. J Tehran Heart Cent 17(4):202–206

PubMed  PubMed Central  Google Scholar 

Mareai RM, Mohammed AQ, Zhang H, Liu L, Zhang W, Mohammed AA, Yin G, Lv X, Xu Y, Abdu FA, Che W (2023) Prognostic implication of coronary slow flow assessed by cTFC in patients with myocardial infarction with Non-obstructive coronary arteries. Eur J Intern Med 108:74–80

Article  PubMed  CAS  Google Scholar 

Stahl LD, Aversano TR, Becker LC (1986) Selective enhancement of function of stunned myocardium by increased flow. Circulation 74(4):843–851

Article  PubMed  CAS  Google Scholar 

Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, Hori M, Higashino Y, Fujii K, Minamino T (1999) Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 33(3):654–660

Article  PubMed  CAS  Google Scholar 

Tokuda T, Hirano K, Oba Y (2024) Successful bail-out with vasodilator injection using dilated over-the-wire balloon for slow-flow phenomenon after drug-coated balloon for superficial femoral artery occlusion. Circ Rep 6(2):30–31

Article  PubMed  PubMed Central  Google Scholar 

Tokuda T, Hirano K, Sakamoto Y, Takimura H, Kobayashi N, Araki M, Yamawaki M, Ito Y (2017) Incidence and clinical outcomes of the slow-flow phenomenon after infrapopliteal balloon angioplasty. J Vasc Surg 65(4):1047–1054

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif